Prominent Lung Cancer Specialist Dr. Tina Roy Joins Virginia Cancer Specialists Team
On August 18, 2026, Virginia Cancer Specialists, recognized as the largest private oncology practice in Northern Virginia, announced the addition of Dr. Tina Roy, a highly esteemed lung cancer specialist and ASCO Young Investigator Award recipient, to its medical team at the Arlington location.
Dr. Tina Roy's expertise in hematology and oncology brings a wealth of knowledge and experience, particularly in the field of lung cancer. She is known for her patient-centered approach, utilizing cutting-edge therapies such as targeted treatments and immunotherapy while ensuring her patients receive tailored, evidence-based care. This aligns seamlessly with the mission of Virginia Cancer Specialists, which is dedicated to providing world-class cancer treatment right in the community,
Dr. Jey A. Maran, president of the practice, expressed excitement about Dr. Roy's arrival, stating, "Dr. Roy is an innovator in the field of oncology, blending compassion with groundbreaking research to improve patient outcomes. Her commitment to advancing treatment methodologies will greatly benefit our patients and collaborating physicians in the region."
Dr. Roy's medical training is impressive. She completed her fellowship in Hematology and Oncology at MedStar Georgetown University Hospital, where she also excelled as Chief Resident in Internal Medicine at both MedStar Georgetown and the Washington D.C. Veterans Affairs Medical Center. Her academic achievements include earning a medical degree from Geisinger Commonwealth School of Medicine, complemented by a bachelor's degree in Bioengineering from Cornell University.
Throughout her distinguished career, Dr. Roy has consistently demonstrated leadership, clinical excellence, and a passion for educating future medical professionals. She has been recognized with numerous accolades, including the Clinical Scholar Award and the prestigious Excellence in Internal Medicine Award, and she was honored by being elected to the Alpha Omega Alpha Honor Medical Society.
Beyond her clinical practice, Dr. Roy is deeply involved in oncology research, contributing her findings to various publications and presenting at multiple national conferences. In a commendable recognition of her work, she received the Conquer Cancer Young Investigator Award in 2026, specifically for her research focusing on HIV-associated lung cancer.
Expressing her enthusiasm about joining Virginia Cancer Specialists, Dr. Roy stated, "As we enter a remarkable era in precision medicine, I am particularly inspired by the possibility of customizing treatment plans based on the distinct biology of each patient’s cancer. I am thrilled to become a part of Virginia Cancer Specialists, and I look forward to fostering meaningful connections with patients while incorporating the latest innovations in cancer treatments."
As of September 14, 2026, Dr. Roy will begin seeing patients at the Virginia Cancer Specialists' Arlington office, situated at 1100 N. Glebe Rd., Suite 1600, 3 Ballston Plaza, Arlington, VA 22201.
Virginia Cancer Specialists has been recognized for three consecutive years as the number one physician practice in Virginia for cancer care, and they provide a broad spectrum of services including medical oncology, radiation oncology, surgical options, genetic counseling, and comprehensive support services. The practice also boasts a robust research institute and maintains the largest clinical trials portfolio in the Mid-Atlantic region, offering state-of-the-art treatment protocols for cancer and blood diseases.
Being part of The US Oncology Network, Virginia Cancer Specialists collaborates with over 600 care sites across 31 states, leveraging collective insights from thousands of patients enrolled in clinical trials. This partnership not only strengthens their capabilities but also enhances the accessibility of cutting-edge cancer therapies and clinical studies.
For more information about Dr. Tina Roy’s expertise and the comprehensive services offered at Virginia Cancer Specialists, you can visit their official website.
Dr. Tina Roy's expertise in hematology and oncology brings a wealth of knowledge and experience, particularly in the field of lung cancer. She is known for her patient-centered approach, utilizing cutting-edge therapies such as targeted treatments and immunotherapy while ensuring her patients receive tailored, evidence-based care. This aligns seamlessly with the mission of Virginia Cancer Specialists, which is dedicated to providing world-class cancer treatment right in the community,
Dr. Jey A. Maran, president of the practice, expressed excitement about Dr. Roy's arrival, stating, "Dr. Roy is an innovator in the field of oncology, blending compassion with groundbreaking research to improve patient outcomes. Her commitment to advancing treatment methodologies will greatly benefit our patients and collaborating physicians in the region."
Dr. Roy's medical training is impressive. She completed her fellowship in Hematology and Oncology at MedStar Georgetown University Hospital, where she also excelled as Chief Resident in Internal Medicine at both MedStar Georgetown and the Washington D.C. Veterans Affairs Medical Center. Her academic achievements include earning a medical degree from Geisinger Commonwealth School of Medicine, complemented by a bachelor's degree in Bioengineering from Cornell University.
Throughout her distinguished career, Dr. Roy has consistently demonstrated leadership, clinical excellence, and a passion for educating future medical professionals. She has been recognized with numerous accolades, including the Clinical Scholar Award and the prestigious Excellence in Internal Medicine Award, and she was honored by being elected to the Alpha Omega Alpha Honor Medical Society.
Beyond her clinical practice, Dr. Roy is deeply involved in oncology research, contributing her findings to various publications and presenting at multiple national conferences. In a commendable recognition of her work, she received the Conquer Cancer Young Investigator Award in 2026, specifically for her research focusing on HIV-associated lung cancer.
Expressing her enthusiasm about joining Virginia Cancer Specialists, Dr. Roy stated, "As we enter a remarkable era in precision medicine, I am particularly inspired by the possibility of customizing treatment plans based on the distinct biology of each patient’s cancer. I am thrilled to become a part of Virginia Cancer Specialists, and I look forward to fostering meaningful connections with patients while incorporating the latest innovations in cancer treatments."
As of September 14, 2026, Dr. Roy will begin seeing patients at the Virginia Cancer Specialists' Arlington office, situated at 1100 N. Glebe Rd., Suite 1600, 3 Ballston Plaza, Arlington, VA 22201.
Virginia Cancer Specialists has been recognized for three consecutive years as the number one physician practice in Virginia for cancer care, and they provide a broad spectrum of services including medical oncology, radiation oncology, surgical options, genetic counseling, and comprehensive support services. The practice also boasts a robust research institute and maintains the largest clinical trials portfolio in the Mid-Atlantic region, offering state-of-the-art treatment protocols for cancer and blood diseases.
Being part of The US Oncology Network, Virginia Cancer Specialists collaborates with over 600 care sites across 31 states, leveraging collective insights from thousands of patients enrolled in clinical trials. This partnership not only strengthens their capabilities but also enhances the accessibility of cutting-edge cancer therapies and clinical studies.
For more information about Dr. Tina Roy’s expertise and the comprehensive services offered at Virginia Cancer Specialists, you can visit their official website.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.